<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <itunes:owner>
            <itunes:name>Welcome to the BioLogicTube</itunes:name>
            <itunes:email>jeo@biologicmedia.dk</itunes:email>
        </itunes:owner>
        <title>Copenhagen Spin-outs</title>
        <link>https://biologictube.dk/app/facebook</link>
        <description></description>
        <language>en-us</language>
        <generator>Visualplatform</generator>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <itunes:author>Welcome to the BioLogicTube</itunes:author>
        <itunes:type>episodic</itunes:type>
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif"/>
        <image>
            <url>https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif</url>
            <title>Copenhagen Spin-outs</title>
            <link>https://biologictube.dk/app/facebook</link>
        </image>
        <atom:link rel="self" href="https://biologictube.dk/app/facebook/rss/app/facebook/channel/7472161"/>
        <atom:link rel="next" href="https://biologictube.dk/app/facebook/rss/app/facebook/channel/7472161?p=2&amp;album%5fid=7472161&amp;app=facebook&amp;podcast%5fp=f&amp;https="/>
        <item>
            <enclosure url="http://biologictube.dk/7718128/9218205/570b78083e2cc33258c4d59ef5a37d9b/video_medium/marianne-thellersen-on-copenhagen-video.mp4?source=podcast" type="video/mp4" length="15210533"/>
            <title>Marianne Thellersen on Copenhagen Spin-outs</title>
            <link>http://biologictube.dk/photo/9218205/marianne-thellersen-on-copenhagen</link>
            <description>&lt;p&gt;&lt;div&gt;&lt;h2&gt;COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS&lt;/h2&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&amp;nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.&lt;/p&gt;&lt;p&gt;Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.&lt;/p&gt;&lt;p&gt;To read more, please visit&amp;nbsp;&lt;a href="http://copenhagenspin-outs.dk/"&gt;http://copenhagenspin-outs.dk/&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/9218205/marianne-thellersen-on-copenhagen"&gt;&lt;img src="http://biologictube.dk/7718128/9218205/570b78083e2cc33258c4d59ef5a37d9b/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/9218205</guid>
            <pubDate>Thu, 23 Jan 2014 11:08:04 GMT</pubDate>
            <media:title>Marianne Thellersen on Copenhagen Spin-outs</media:title>
            <itunes:summary>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.To read more, please visithttp://copenhagenspin-outs.dk/</itunes:summary>
            <itunes:subtitle>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>02:38</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;div&gt;&lt;h2&gt;COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS&lt;/h2&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&amp;nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.&lt;/p&gt;&lt;p&gt;Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.&lt;/p&gt;&lt;p&gt;To read more, please visit&amp;nbsp;&lt;a href="http://copenhagenspin-outs.dk/"&gt;http://copenhagenspin-outs.dk/&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/9218205/marianne-thellersen-on-copenhagen"&gt;&lt;img src="http://biologictube.dk/7718128/9218205/570b78083e2cc33258c4d59ef5a37d9b/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=570b78083e2cc33258c4d59ef5a37d9b&amp;source=podcast&amp;photo%5fid=9218205" width="625" height="352" type="text/html" medium="video" duration="158" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7718128/9218205/570b78083e2cc33258c4d59ef5a37d9b/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7718128/9218205/570b78083e2cc33258c4d59ef5a37d9b/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>Biologicmedia</category>
            <category>Denmarks technical University</category>
            <category>Gert Balling</category>
            <category>IPR</category>
            <category>Tech trans</category>
            <category>commercialization</category>
            <category>from bench to bedside</category>
            <category>improving</category>
            <category>innovation</category>
            <category>motivation</category>
            <category>spin out</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7718127/8891733/fa66592dd9f7490c426951338b50354e/video_medium/director-kim-hogh-on-copenhagen-video.mp4?source=podcast" type="video/mp4" length="17054992"/>
            <title>Director Kim Høgh on Copenhagen Spin-outs</title>
            <link>http://biologictube.dk/photo/8891733/director-kim-hogh-on-copenhagen</link>
            <description>&lt;p&gt;&lt;div&gt;&lt;div&gt;&lt;h2&gt;COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS&lt;/h2&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Interview with Director Kim Høgh from Capital region of Denmark&amp;nbsp;on Copenhagen Spin-outs.&amp;nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.&lt;/p&gt;&lt;p&gt;Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.&lt;/p&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/8891733/director-kim-hogh-on-copenhagen"&gt;&lt;img src="http://biologictube.dk/7718127/8891733/fa66592dd9f7490c426951338b50354e/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/8891733</guid>
            <pubDate>Tue, 21 Jan 2014 10:54:03 GMT</pubDate>
            <media:title>Director Kim Høgh on Copenhagen Spin-outs</media:title>
            <itunes:summary>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSInterview with Director Kim Høgh from Capital region of Denmarkon Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.</itunes:summary>
            <itunes:subtitle>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSInterview with Director Kim Høgh from Capital region of Denmarkon Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>02:26</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;div&gt;&lt;div&gt;&lt;h2&gt;COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS&lt;/h2&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Interview with Director Kim Høgh from Capital region of Denmark&amp;nbsp;on Copenhagen Spin-outs.&amp;nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.&lt;/p&gt;&lt;p&gt;Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.&lt;/p&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/8891733/director-kim-hogh-on-copenhagen"&gt;&lt;img src="http://biologictube.dk/7718127/8891733/fa66592dd9f7490c426951338b50354e/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=fa66592dd9f7490c426951338b50354e&amp;source=podcast&amp;photo%5fid=8891733" width="625" height="352" type="text/html" medium="video" duration="146" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7718127/8891733/fa66592dd9f7490c426951338b50354e/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7718127/8891733/fa66592dd9f7490c426951338b50354e/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7718124/9208451/96b3c731c90b012563901fed6ba84dce/video_medium/prorector-thomas-bjornholm-and-video.mp4?source=podcast" type="video/mp4" length="16683822"/>
            <title>Prorector Thomas Bjørnholm and Copenhagen Spin-outs</title>
            <link>http://biologictube.dk/photo/9208451/prorector-thomas-bjornholm-and</link>
            <description>&lt;p&gt;&lt;div&gt;&lt;div&gt;&lt;h2&gt;COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS&lt;/h2&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&amp;nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.&lt;/p&gt;&lt;p&gt;Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.&lt;/p&gt;&lt;p&gt;To read more, please visit&amp;nbsp;&lt;a href="http://copenhagenspin-outs.dk/"&gt;http://copenhagenspin-outs.dk/&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/9208451/prorector-thomas-bjornholm-and"&gt;&lt;img src="http://biologictube.dk/7718124/9208451/96b3c731c90b012563901fed6ba84dce/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/9208451</guid>
            <pubDate>Tue, 21 Jan 2014 10:48:53 GMT</pubDate>
            <media:title>Prorector Thomas Bjørnholm and Copenhagen Spin-outs</media:title>
            <itunes:summary>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.To read more, please visithttp://copenhagenspin-outs.dk/</itunes:summary>
            <itunes:subtitle>COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORSProrector at University of Copenhagen is interviewed about Copenhagen Spin-outs.Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>03:52</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;div&gt;&lt;div&gt;&lt;h2&gt;COLLABORATION BETWEEN RESEARCH, INDUSTRY AND INVESTORS&lt;/h2&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Prorector at University of Copenhagen is interviewed about Copenhagen Spin-outs.&amp;nbsp;Copenhagen Spin-outs is a collaboration between the academic research environment and industry with a focus on innovation and commercialisation of biotech research in the capital region area. In the project we will focus on strenthening the collaboration between universities, research parks and investors to speed up the effort to promote the good ideas from the research institutions and turn them into sustainable biotech companies. The spin-outs will work within the areas of MedTech, Diagnostics, Pharmaceuticals as well as Industrial biotech and Food.&lt;/p&gt;&lt;p&gt;Copenhagen Spin-outs run from 2012-2014, and is funded with 20 million DKK from EU Regional Fund, 8 million DKK from the Captal Regions Growth Forum and 12 million DKK from the partners.&lt;/p&gt;&lt;p&gt;To read more, please visit&amp;nbsp;&lt;a href="http://copenhagenspin-outs.dk/"&gt;http://copenhagenspin-outs.dk/&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/9208451/prorector-thomas-bjornholm-and"&gt;&lt;img src="http://biologictube.dk/7718124/9208451/96b3c731c90b012563901fed6ba84dce/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=96b3c731c90b012563901fed6ba84dce&amp;source=podcast&amp;photo%5fid=9208451" width="625" height="352" type="text/html" medium="video" duration="232" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7718124/9208451/96b3c731c90b012563901fed6ba84dce/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7718124/9208451/96b3c731c90b012563901fed6ba84dce/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>Gert Balling</category>
            <category>Venture</category>
            <category>commercialization</category>
            <category>entrepreneurship</category>
            <category>from bench to bedside</category>
            <category>invest</category>
            <category>ipr</category>
            <category>patents</category>
            <category>research</category>
            <category>start-up</category>
            <category>university</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7718125/7846595/d1aa51b858f4b2c9a6cc8d74bb66b26c/video_medium/copenhagen-spin-outs-by-gert-balling-video.mp4?source=podcast" type="video/mp4" length="11050282"/>
            <title>Copenhagen Spin-outs by Gert Balling. Introduction. Short Version.</title>
            <link>http://biologictube.dk/photo/7846595/copenhagen-spin-outs-by-gert-balling</link>
            <description>&lt;p&gt;Copenhagen Spin-outs by Gert Balling. Introduction. Short Version.&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7846595/copenhagen-spin-outs-by-gert-balling"&gt;&lt;img src="http://biologictube.dk/7718125/7846595/d1aa51b858f4b2c9a6cc8d74bb66b26c/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7846595</guid>
            <pubDate>Thu, 07 Mar 2013 11:30:08 GMT</pubDate>
            <media:title>Copenhagen Spin-outs by Gert Balling. Introduction. Short Version.</media:title>
            <itunes:summary>Copenhagen Spin-outs by Gert Balling. Introduction. Short Version.</itunes:summary>
            <itunes:subtitle>Copenhagen Spin-outs by Gert Balling. Introduction. Short Version.</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>01:26</itunes:duration>
            <media:description type="html">&lt;p&gt;Copenhagen Spin-outs by Gert Balling. Introduction. Short Version.&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7846595/copenhagen-spin-outs-by-gert-balling"&gt;&lt;img src="http://biologictube.dk/7718125/7846595/d1aa51b858f4b2c9a6cc8d74bb66b26c/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=d1aa51b858f4b2c9a6cc8d74bb66b26c&amp;source=podcast&amp;photo%5fid=7846595" width="625" height="352" type="text/html" medium="video" duration="86" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7718125/7846595/d1aa51b858f4b2c9a6cc8d74bb66b26c/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7718125/7846595/d1aa51b858f4b2c9a6cc8d74bb66b26c/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>balling</category>
            <category>capital</category>
            <category>denmark</category>
            <category>dtu</category>
            <category>gert</category>
            <category>hovedstaden</category>
            <category>industry</category>
            <category>innovation</category>
            <category>know-how</category>
            <category>københavns</category>
            <category>medtech</category>
            <category>patents</category>
            <category>pharmaceuticals</category>
            <category>products</category>
            <category>region</category>
            <category>tech</category>
            <category>technology</category>
            <category>transfer</category>
            <category>universitet</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7718127/7846651/67651711ad9d07fde41e1b19372e624d/video_medium/copenhagen-spin-outs-gert-balling-video.mp4?source=podcast" type="video/mp4" length="12373504"/>
            <title>Copenhagen Spin-outs - Gert Balling. Introduction. Long Version.</title>
            <link>http://biologictube.dk/photo/7846651/copenhagen-spin-outs-gert-balling</link>
            <description>&lt;p&gt;Copenhagen Spin-outs - Gert Balling. Introduction. Long Version.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7846651/copenhagen-spin-outs-gert-balling"&gt;&lt;img src="http://biologictube.dk/7718127/7846651/67651711ad9d07fde41e1b19372e624d/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7846651</guid>
            <pubDate>Thu, 07 Mar 2013 11:29:25 GMT</pubDate>
            <media:title>Copenhagen Spin-outs - Gert Balling. Introduction. Long Version.</media:title>
            <itunes:summary>Copenhagen Spin-outs - Gert Balling. Introduction. Long Version.</itunes:summary>
            <itunes:subtitle>Copenhagen Spin-outs - Gert Balling. Introduction. Long Version.</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>01:36</itunes:duration>
            <media:description type="html">&lt;p&gt;Copenhagen Spin-outs - Gert Balling. Introduction. Long Version.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7846651/copenhagen-spin-outs-gert-balling"&gt;&lt;img src="http://biologictube.dk/7718127/7846651/67651711ad9d07fde41e1b19372e624d/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=67651711ad9d07fde41e1b19372e624d&amp;source=podcast&amp;photo%5fid=7846651" width="625" height="352" type="text/html" medium="video" duration="96" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7718127/7846651/67651711ad9d07fde41e1b19372e624d/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7718127/7846651/67651711ad9d07fde41e1b19372e624d/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>Balling</category>
            <category>DTU</category>
            <category>Denmark</category>
            <category>Gert</category>
            <category>Hovedstaden</category>
            <category>Innovation</category>
            <category>Know-how</category>
            <category>Københavns</category>
            <category>Medtech</category>
            <category>Patents</category>
            <category>Pharmaceuticals</category>
            <category>Products</category>
            <category>Region</category>
            <category>Tech</category>
            <category>Technology</category>
            <category>Transfer</category>
            <category>Universitet</category>
            <category>capital</category>
            <category>industry</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7524589/83d77a226d3e941cb1de65c45138bc44/video_medium/interview-with-jeff-skinner-executive-video.mp4?source=podcast" type="video/mp4" length="17970622"/>
            <title>Interview with Jeff Skinner, Executive director at London Business School </title>
            <link>http://biologictube.dk/photo/7524589/interview-with-jeff-skinner-executive</link>
            <description>&lt;p&gt;&lt;p&gt;&lt;b&gt;Jeff Skinner,&lt;/b&gt; Executive Director, Deloitte Institute of Innovation and Entrepreneurship, London Business School, explains what it takes to make it and how value is build in the biotech industry. Jeff Skinner was in Copenhagen to lecture at the Copenhagen Spin-outs conference in October 2012 and we interviewed him after his lecture.&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Jeff Skinner is the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.&lt;/p&gt;
&lt;p&gt;He is past President of and remains closely involved with the leading UK &amp;amp; European Tech Transfer Associations (PraxisUnico &amp;amp; ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.&lt;/p&gt;
&lt;p&gt;Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.&lt;/p&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7524589/interview-with-jeff-skinner-executive"&gt;&lt;img src="http://biologictube.dk/7522146/7524589/83d77a226d3e941cb1de65c45138bc44/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7524589</guid>
            <pubDate>Mon, 11 Feb 2013 20:17:48 GMT</pubDate>
            <media:title>Interview with Jeff Skinner, Executive director at London Business School </media:title>
            <itunes:summary>Jeff Skinner, Executive Director, Deloitte Institute of Innovation and Entrepreneurship, London Business School, explains what it takes to make it and how value is build in the biotech industry. Jeff Skinner was in Copenhagen to lecture at the Copenhagen Spin-outs conference in October 2012 and we interviewed him after his lecture.

Jeff Skinner is the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.
He is past President of and remains closely involved with the leading UK  European Tech Transfer Associations (PraxisUnico  ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.
Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.</itunes:summary>
            <itunes:subtitle>Jeff Skinner, Executive Director, Deloitte Institute of Innovation and Entrepreneurship, London Business School, explains what it takes to make it and how value is build in the biotech industry. Jeff Skinner was in Copenhagen to lecture at the...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>02:15</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;&lt;b&gt;Jeff Skinner,&lt;/b&gt; Executive Director, Deloitte Institute of Innovation and Entrepreneurship, London Business School, explains what it takes to make it and how value is build in the biotech industry. Jeff Skinner was in Copenhagen to lecture at the Copenhagen Spin-outs conference in October 2012 and we interviewed him after his lecture.&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Jeff Skinner is the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.&lt;/p&gt;
&lt;p&gt;He is past President of and remains closely involved with the leading UK &amp;amp; European Tech Transfer Associations (PraxisUnico &amp;amp; ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.&lt;/p&gt;
&lt;p&gt;Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.&lt;/p&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7524589/interview-with-jeff-skinner-executive"&gt;&lt;img src="http://biologictube.dk/7522146/7524589/83d77a226d3e941cb1de65c45138bc44/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=83d77a226d3e941cb1de65c45138bc44&amp;source=podcast&amp;photo%5fid=7524589" width="625" height="352" type="text/html" medium="video" duration="135" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7524589/83d77a226d3e941cb1de65c45138bc44/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7524589/83d77a226d3e941cb1de65c45138bc44/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>Building</category>
            <category>commercialization</category>
            <category>experience</category>
            <category>knowledge</category>
            <category>patents</category>
            <category>patience</category>
            <category>sustainability</category>
            <category>value</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7672183/e13bb9b57f2047ea520d1b13c0b60a12/video_medium/karen-laigaard-opening-words-video.mp4?source=podcast" type="video/mp4" length="96645340"/>
            <title>Karen Laigaard - opening words at the Spin Out conference</title>
            <link>http://biologictube.dk/photo/7672183/karen-laigaard-opening-words</link>
            <description>&lt;p&gt;&lt;div&gt;Opening words at the Call for Spin-outs conference in Copenhagen October 2012&lt;br&gt;Karen Laigaard joined the University of Copenhagen in March 2003 to set up and manage Copenhagen University’s Technology Transfer Office. The University has six faculties 37,000 students and 8,500 employees (of which 5,500 researchers).&lt;br&gt;The Tech Transfer Office staff (12 people) are responsible for the identification, the protection and the commercialisation of Copenhagen University’s research results. The Office receives around 60 invention disclosures per year, it entered 21 licensing agreements in 2011 on behalf of the University and the office also assists academic staff with a considerable amount of research collaboration agreements. The Office’s newest initiative is the project, “Copenhagen Spin-outs”, a collaboration between three TTOs and central stake holders who will work together to create more biotech spin-outs from academia. The project has a total budget of 5.4 EUR.&lt;br&gt;Karen lived and worked in the United Kingdom from 1992 to 2001. She was employed for six years with the University of Glasgow’s commercialisation office, Research &amp;amp; Enterprise. As the office’s International Marketing Manager she was responsible for the international promotion of the University’s research expertise. Prior to joining Research &amp;amp; Enterprise, Karen worked at The British Council, Scotland, on an export promotion project funded by the UK Department of Trade &amp;amp; Industry and Scottish Trade International.&lt;br&gt;From 2007 to 2011 Karen was a member of the board of ASTP (Association of European Science &amp;amp; Technology Transfer Professionals) and was the President of ASTP from May 2009 till May 2011.&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7672183/karen-laigaard-opening-words"&gt;&lt;img src="http://biologictube.dk/7522146/7672183/e13bb9b57f2047ea520d1b13c0b60a12/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7672183</guid>
            <pubDate>Wed, 30 Jan 2013 11:14:02 GMT</pubDate>
            <media:title>Karen Laigaard - opening words at the Spin Out conference</media:title>
            <itunes:summary>Opening words at the Call for Spin-outs conference in Copenhagen October 2012Karen Laigaard joined the University of Copenhagen in March 2003 to set up and manage Copenhagen University’s Technology Transfer Office. The University has six faculties 37,000 students and 8,500 employees (of which 5,500 researchers).The Tech Transfer Office staff (12 people) are responsible for the identification, the protection and the commercialisation of Copenhagen University’s research results. The Office receives around 60 invention disclosures per year, it entered 21 licensing agreements in 2011 on behalf of the University and the office also assists academic staff with a considerable amount of research collaboration agreements. The Office’s newest initiative is the project, “Copenhagen Spin-outs”, a collaboration between three TTOs and central stake holders who will work together to create more biotech spin-outs from academia. The project has a total budget of 5.4 EUR.Karen lived and worked in the United Kingdom from 1992 to 2001. She was employed for six years with the University of Glasgow’s commercialisation office, Research  Enterprise. As the office’s International Marketing Manager she was responsible for the international promotion of the University’s research expertise. Prior to joining Research  Enterprise, Karen worked at The British Council, Scotland, on an export promotion project funded by the UK Department of Trade  Industry and Scottish Trade International.From 2007 to 2011 Karen was a member of the board of ASTP (Association of European Science  Technology Transfer Professionals) and was the President of ASTP from May 2009 till May 2011.</itunes:summary>
            <itunes:subtitle>Opening words at the Call for Spin-outs conference in Copenhagen October 2012Karen Laigaard joined the University of Copenhagen in March 2003 to set up and manage Copenhagen University’s Technology Transfer Office. The University has six faculties...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>12:30</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;div&gt;Opening words at the Call for Spin-outs conference in Copenhagen October 2012&lt;br&gt;Karen Laigaard joined the University of Copenhagen in March 2003 to set up and manage Copenhagen University’s Technology Transfer Office. The University has six faculties 37,000 students and 8,500 employees (of which 5,500 researchers).&lt;br&gt;The Tech Transfer Office staff (12 people) are responsible for the identification, the protection and the commercialisation of Copenhagen University’s research results. The Office receives around 60 invention disclosures per year, it entered 21 licensing agreements in 2011 on behalf of the University and the office also assists academic staff with a considerable amount of research collaboration agreements. The Office’s newest initiative is the project, “Copenhagen Spin-outs”, a collaboration between three TTOs and central stake holders who will work together to create more biotech spin-outs from academia. The project has a total budget of 5.4 EUR.&lt;br&gt;Karen lived and worked in the United Kingdom from 1992 to 2001. She was employed for six years with the University of Glasgow’s commercialisation office, Research &amp;amp; Enterprise. As the office’s International Marketing Manager she was responsible for the international promotion of the University’s research expertise. Prior to joining Research &amp;amp; Enterprise, Karen worked at The British Council, Scotland, on an export promotion project funded by the UK Department of Trade &amp;amp; Industry and Scottish Trade International.&lt;br&gt;From 2007 to 2011 Karen was a member of the board of ASTP (Association of European Science &amp;amp; Technology Transfer Professionals) and was the President of ASTP from May 2009 till May 2011.&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7672183/karen-laigaard-opening-words"&gt;&lt;img src="http://biologictube.dk/7522146/7672183/e13bb9b57f2047ea520d1b13c0b60a12/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=e13bb9b57f2047ea520d1b13c0b60a12&amp;source=podcast&amp;photo%5fid=7672183" width="625" height="352" type="text/html" medium="video" duration="750" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7672183/e13bb9b57f2047ea520d1b13c0b60a12/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7672183/e13bb9b57f2047ea520d1b13c0b60a12/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7529380/2727abd69eb8fe7c97de4a12e6932098/video_medium/the-value-of-spin-outs-by-video.mp4?source=podcast" type="video/mp4" length="246309547"/>
            <title>The value of Spin-outs by Martin Bonde, Chairman Dansk Biotek and Copenhagen...</title>
            <link>http://biologictube.dk/photo/7529380/the-value-of-spin-outs-by</link>
            <description>&lt;p&gt;What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7529380/the-value-of-spin-outs-by"&gt;&lt;img src="http://biologictube.dk/7522146/7529380/2727abd69eb8fe7c97de4a12e6932098/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7529380</guid>
            <pubDate>Tue, 29 Jan 2013 20:18:54 GMT</pubDate>
            <media:title>The value of Spin-outs by Martin Bonde, Chairman Dansk Biotek and Copenhagen...</media:title>
            <itunes:summary>What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.</itunes:summary>
            <itunes:subtitle>What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>31:45</itunes:duration>
            <media:description type="html">&lt;p&gt;What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7529380/the-value-of-spin-outs-by"&gt;&lt;img src="http://biologictube.dk/7522146/7529380/2727abd69eb8fe7c97de4a12e6932098/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=2727abd69eb8fe7c97de4a12e6932098&amp;source=podcast&amp;photo%5fid=7529380" width="625" height="352" type="text/html" medium="video" duration="1905" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7529380/2727abd69eb8fe7c97de4a12e6932098/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7529380/2727abd69eb8fe7c97de4a12e6932098/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>IPR</category>
            <category>biotech</category>
            <category>biotek</category>
            <category>capital</category>
            <category>creation</category>
            <category>danish</category>
            <category>dansk</category>
            <category>job</category>
            <category>region</category>
            <category>research</category>
            <category>talents</category>
            <category>technology transfer</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7530049/e5ce28f1db9c3efeafe47870df828b79/video_medium/wim-bens-talks-about-his-video.mp4?source=podcast" type="video/mp4" length="539994765"/>
            <title>Wim Bens talks about his experience from the Netherlands in setting up...</title>
            <link>http://biologictube.dk/photo/7530049/wim-bens-talks-about-his</link>
            <description>&lt;p&gt;&lt;p&gt;Experience from the Netherlands in setting up University Spin-outs &lt;b&gt;Wim Bens&lt;/b&gt;, Director, Bens &amp;amp; Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy and implementation from lab invention to successful enterprise through different stages, with different funding structures, with different teams and in different organizational settings.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7530049/wim-bens-talks-about-his"&gt;&lt;img src="http://biologictube.dk/7522146/7530049/e5ce28f1db9c3efeafe47870df828b79/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7530049</guid>
            <pubDate>Mon, 31 Dec 2012 14:47:32 GMT</pubDate>
            <media:title>Wim Bens talks about his experience from the Netherlands in setting up...</media:title>
            <itunes:summary>Experience from the Netherlands in setting up University Spin-outs Wim Bens, Director, Bens  Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy and implementation from lab invention to successful enterprise through different stages, with different funding structures, with different teams and in different organizational settings.</itunes:summary>
            <itunes:subtitle>Experience from the Netherlands in setting up University Spin-outs Wim Bens, Director, Bens  Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>01:09:00</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;Experience from the Netherlands in setting up University Spin-outs &lt;b&gt;Wim Bens&lt;/b&gt;, Director, Bens &amp;amp; Partners Management en Advies, Eindhoven Business cases in setting up spin outs / high tech start ups in a regional open innovation eco system. Strategy and implementation from lab invention to successful enterprise through different stages, with different funding structures, with different teams and in different organizational settings.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7530049/wim-bens-talks-about-his"&gt;&lt;img src="http://biologictube.dk/7522146/7530049/e5ce28f1db9c3efeafe47870df828b79/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=e5ce28f1db9c3efeafe47870df828b79&amp;source=podcast&amp;photo%5fid=7530049" width="625" height="352" type="text/html" medium="video" duration="4140" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7530049/e5ce28f1db9c3efeafe47870df828b79/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7530049/e5ce28f1db9c3efeafe47870df828b79/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>IPR</category>
            <category>building</category>
            <category>business</category>
            <category>copebhagen</category>
            <category>outs</category>
            <category>patents</category>
            <category>private</category>
            <category>public</category>
            <category>spin</category>
            <category>technology</category>
            <category>techtrans</category>
            <category>transfer</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7530745/ef0b3f0ece6fe971f78680e32924068b/video_medium/jeff-skinner-director-london-video.mp4?source=podcast" type="video/mp4" length="514240979"/>
            <title>Jeff Skinner, Director,  London Business School, talks on his experience from...</title>
            <link>http://biologictube.dk/photo/7530745/jeff-skinner-director-london</link>
            <description>&lt;p&gt;&lt;p&gt;&lt;b&gt;Jeff Skinner&lt;/b&gt;&amp;nbsp;is the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.&lt;/p&gt;&lt;p&gt;He is past President of and remains closely involved with the leading UK &amp;amp; European Tech Transfer Associations (PraxisUnico &amp;amp; ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.&lt;/p&gt;&lt;p&gt;Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7530745/jeff-skinner-director-london"&gt;&lt;img src="http://biologictube.dk/7522146/7530745/ef0b3f0ece6fe971f78680e32924068b/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7530745</guid>
            <pubDate>Mon, 31 Dec 2012 14:43:27 GMT</pubDate>
            <media:title>Jeff Skinner, Director,  London Business School, talks on his experience from...</media:title>
            <itunes:summary>Jeff Skinneris the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.He is past President of and remains closely involved with the leading UK  European Tech Transfer Associations (PraxisUnico  ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.</itunes:summary>
            <itunes:subtitle>Jeff Skinneris the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>01:06:00</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;&lt;b&gt;Jeff Skinner&lt;/b&gt;&amp;nbsp;is the Executive Director of the Deloitte Institute of Innovation and Entrepreneurship at London Business School. He also directs a variety of MBA entrepreneurship electives and co-curricula student activities at the School. He is visiting lecturer on Technology Transfer at University College London and at the Graduate School of Economics in Barcelona. Prior to this, as Commercial Director at University College London, he conceived, built and ran UCL’s Technology Transfer division - including the creation of two early-stage seed funds and separate units managing consultancy, collaborative research and new venture creation. Working alongside research students and academics he has co-founded over thirty technology-based spin-outs that have, in aggregate, raised over £30 million first round finance and returned over £20 million to UCL.&lt;/p&gt;&lt;p&gt;He is past President of and remains closely involved with the leading UK &amp;amp; European Tech Transfer Associations (PraxisUnico &amp;amp; ASTP). He teaches and consults widely throughout Europe in the field of technology commercialisation. He Chairs the Professional Recognition panel for the worldwide ‘Alliance of Technology Transfer Professionals’.&lt;/p&gt;&lt;p&gt;Before joining UCL he was Technical Marketing Manager at Hoechst Celanese Corporation in New Jersey and prior to that, Photonics Research Manager at General Electric. His first degree was in physics. He holds a PhD in thin-film photonics from University College London and an MBA from London Business School.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7530745/jeff-skinner-director-london"&gt;&lt;img src="http://biologictube.dk/7522146/7530745/ef0b3f0ece6fe971f78680e32924068b/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=ef0b3f0ece6fe971f78680e32924068b&amp;source=podcast&amp;photo%5fid=7530745" width="625" height="352" type="text/html" medium="video" duration="3960" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7530745/ef0b3f0ece6fe971f78680e32924068b/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7530745/ef0b3f0ece6fe971f78680e32924068b/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>Balling</category>
            <category>Copenhagen</category>
            <category>Gert</category>
            <category>IPR</category>
            <category>Spin</category>
            <category>biotech</category>
            <category>building</category>
            <category>chain</category>
            <category>innovation</category>
            <category>outs</category>
            <category>patents</category>
            <category>value</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7529488/f072826196e42f005a29e483f7cce144/video_medium/jens-kristian-damgaard-video.mp4?source=podcast" type="video/mp4" length="269881847"/>
            <title>Jens Kristian Damgaard; Challenges in creating companies in the field between...</title>
            <link>http://biologictube.dk/photo/7529488/jens-kristian-damgaard</link>
            <description>&lt;p&gt;Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. &lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7529488/jens-kristian-damgaard"&gt;&lt;img src="http://biologictube.dk/7522146/7529488/f072826196e42f005a29e483f7cce144/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7529488</guid>
            <pubDate>Sun, 30 Dec 2012 20:13:22 GMT</pubDate>
            <media:title>Jens Kristian Damgaard; Challenges in creating companies in the field between...</media:title>
            <itunes:summary>Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. </itunes:summary>
            <itunes:subtitle>Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. </itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>34:49</itunes:duration>
            <media:description type="html">&lt;p&gt;Jens Kristian Damgaard, Director at Science Ventures Denmark, talks on the considerations that go behind the decision to spin out a project from the public to private marked. &lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7529488/jens-kristian-damgaard"&gt;&lt;img src="http://biologictube.dk/7522146/7529488/f072826196e42f005a29e483f7cce144/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=f072826196e42f005a29e483f7cce144&amp;source=podcast&amp;photo%5fid=7529488" width="625" height="352" type="text/html" medium="video" duration="2089" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7529488/f072826196e42f005a29e483f7cce144/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7529488/f072826196e42f005a29e483f7cce144/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>Balling</category>
            <category>Gert</category>
            <category>IPR</category>
            <category>MTA</category>
            <category>collaboration</category>
            <category>outs</category>
            <category>patents</category>
            <category>spin</category>
            <category>technology</category>
            <category>transfer</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7525099/d61f3cb3a2f6de363b28e3766689578a/video_medium/henric-rhedin-talks-on-the-video.mp4?source=podcast" type="video/mp4" length="257740868"/>
            <title>Henric Rhedin talks on the swedish innovator system</title>
            <link>http://biologictube.dk/photo/7525099/henric-rhedin-talks-on-the</link>
            <description>&lt;p&gt;&lt;p&gt;Sweden’s so called innovation system; a spin out creation system. &lt;br&gt;&lt;/p&gt;&lt;p&gt;Henric Rhedin. Director of Sales &amp;amp; Marketing, Commercial Research 
&amp;amp; Development. Chalmers Industriteknik, Gothenburg In Sweden there 
has been a focus on creating spin outs as commercialization strategy. 
What are the advan-tages/ disadvantages with a “spin out creation 
system” compared to more regular “innovation systems&lt;/p&gt;&lt;p&gt;Chalmers 
Industrial Technologies (CIT) is Sweden ́s oldest technology transfer 
organization and dates back to 1984. Henric works since nine years back 
for the largest unit at CIT, 35 people out of a total of 75 people 
employed by CIT. The unit, Commercial R&amp;amp;D, provides expertise in all
 kinds of areas of technology including technology management and 
related services.&lt;/p&gt;
&lt;p&gt;Henric is board member for several start up companies as well as 
organizations. In addition to this Henric is active in innovation system
 networks on the national as well as on the international level 
including Association of Science and Technology Transfer Professional 
(ASTP), HEP TTN a CERN centered network for technology transfer 
activities for high energy physics, Swedish Network for Innovation and 
Tech Transfer Support (SNITTS) and Nordic Tech Transfer Network Health 
(NORTTH). Henric has also worked in the Swedish defense industry and has
 a PhD in Theoretical High Energy Physics.&lt;/p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7525099/henric-rhedin-talks-on-the"&gt;&lt;img src="http://biologictube.dk/7522146/7525099/d61f3cb3a2f6de363b28e3766689578a/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7525099</guid>
            <pubDate>Sat, 29 Dec 2012 16:06:01 GMT</pubDate>
            <media:title>Henric Rhedin talks on the swedish innovator system</media:title>
            <itunes:summary>Sweden’s so called innovation system; a spin out creation system. Henric Rhedin. Director of Sales  Marketing, Commercial Research 
 Development. Chalmers Industriteknik, Gothenburg In Sweden there 
has been a focus on creating spin outs as commercialization strategy. 
What are the advan-tages/ disadvantages with a “spin out creation 
system” compared to more regular “innovation systemsChalmers 
Industrial Technologies (CIT) is Sweden ́s oldest technology transfer 
organization and dates back to 1984. Henric works since nine years back 
for the largest unit at CIT, 35 people out of a total of 75 people 
employed by CIT. The unit, Commercial RD, provides expertise in all
 kinds of areas of technology including technology management and 
related services.
Henric is board member for several start up companies as well as 
organizations. In addition to this Henric is active in innovation system
 networks on the national as well as on the international level 
including Association of Science and Technology Transfer Professional 
(ASTP), HEP TTN a CERN centered network for technology transfer 
activities for high energy physics, Swedish Network for Innovation and 
Tech Transfer Support (SNITTS) and Nordic Tech Transfer Network Health 
(NORTTH). Henric has also worked in the Swedish defense industry and has
 a PhD in Theoretical High Energy Physics.</itunes:summary>
            <itunes:subtitle>Sweden’s so called innovation system; a spin out creation system. Henric Rhedin. Director of Sales  Marketing, Commercial Research 
 Development. Chalmers Industriteknik, Gothenburg In Sweden there 
has been a focus on creating spin outs as...</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>33:15</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;Sweden’s so called innovation system; a spin out creation system. &lt;br&gt;&lt;/p&gt;&lt;p&gt;Henric Rhedin. Director of Sales &amp;amp; Marketing, Commercial Research 
&amp;amp; Development. Chalmers Industriteknik, Gothenburg In Sweden there 
has been a focus on creating spin outs as commercialization strategy. 
What are the advan-tages/ disadvantages with a “spin out creation 
system” compared to more regular “innovation systems&lt;/p&gt;&lt;p&gt;Chalmers 
Industrial Technologies (CIT) is Sweden ́s oldest technology transfer 
organization and dates back to 1984. Henric works since nine years back 
for the largest unit at CIT, 35 people out of a total of 75 people 
employed by CIT. The unit, Commercial R&amp;amp;D, provides expertise in all
 kinds of areas of technology including technology management and 
related services.&lt;/p&gt;
&lt;p&gt;Henric is board member for several start up companies as well as 
organizations. In addition to this Henric is active in innovation system
 networks on the national as well as on the international level 
including Association of Science and Technology Transfer Professional 
(ASTP), HEP TTN a CERN centered network for technology transfer 
activities for high energy physics, Swedish Network for Innovation and 
Tech Transfer Support (SNITTS) and Nordic Tech Transfer Network Health 
(NORTTH). Henric has also worked in the Swedish defense industry and has
 a PhD in Theoretical High Energy Physics.&lt;/p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7525099/henric-rhedin-talks-on-the"&gt;&lt;img src="http://biologictube.dk/7522146/7525099/d61f3cb3a2f6de363b28e3766689578a/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=d61f3cb3a2f6de363b28e3766689578a&amp;source=podcast&amp;photo%5fid=7525099" width="625" height="352" type="text/html" medium="video" duration="1995" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7525099/d61f3cb3a2f6de363b28e3766689578a/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7525099/d61f3cb3a2f6de363b28e3766689578a/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>Experience</category>
            <category>IPR</category>
            <category>biotech</category>
            <category>commercialization</category>
            <category>patents</category>
            <category>technology</category>
            <category>transfer</category>
        </item>
        <item>
            <enclosure url="http://biologictube.dk/7522146/7526773/792a0844db51cc49da9088e78be2bdfd/video_medium/there-is-a-need-to-strengthen-video.mp4?source=podcast" type="video/mp4" length="322382398"/>
            <title>There is a need to strengthen and stimulate the cooperation between...</title>
            <link>http://biologictube.dk/photo/7526773/there-is-a-need-to-strengthen</link>
            <description>&lt;p&gt;&lt;p&gt;Thomas Christiansen explains the&amp;nbsp;Government perspective on bridging public research and industry&lt;/p&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7526773/there-is-a-need-to-strengthen"&gt;&lt;img src="http://biologictube.dk/7522146/7526773/792a0844db51cc49da9088e78be2bdfd/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://biologictube.dk/photo/7526773</guid>
            <pubDate>Sun, 30 Dec 2012 09:24:04 GMT</pubDate>
            <media:title>There is a need to strengthen and stimulate the cooperation between...</media:title>
            <itunes:summary>Thomas Christiansen explains theGovernment perspective on bridging public research and industry</itunes:summary>
            <itunes:subtitle>Thomas Christiansen explains theGovernment perspective on bridging public research and industry</itunes:subtitle>
            <itunes:author>Welcome to the BioLogicTube</itunes:author>
            <itunes:duration>43:28</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;Thomas Christiansen explains the&amp;nbsp;Government perspective on bridging public research and industry&lt;/p&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://biologictube.dk/photo/7526773/there-is-a-need-to-strengthen"&gt;&lt;img src="http://biologictube.dk/7522146/7526773/792a0844db51cc49da9088e78be2bdfd/standard/download-1-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//biologictube.dk/v.ihtml/player.html?token=792a0844db51cc49da9088e78be2bdfd&amp;source=podcast&amp;photo%5fid=7526773" width="625" height="352" type="text/html" medium="video" duration="2608" isDefault="true" expression="full"/>
            <media:thumbnail url="http://biologictube.dk/7522146/7526773/792a0844db51cc49da9088e78be2bdfd/standard/download-1-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://biologictube.dk/7522146/7526773/792a0844db51cc49da9088e78be2bdfd/standard/download-1-thumbnail.jpg/thumbnail.jpg"/>
            <category>biotech</category>
            <category>funding</category>
            <category>future</category>
            <category>jobs</category>
            <category>key</category>
            <category>politics</category>
            <category>sector</category>
            <category>technology transfer</category>
            <category>view</category>
        </item>
    </channel>
</rss>
